Your browser doesn't support javascript.
Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles, Angel; Satue-Gracia, Eva; Ochoa-Gondar, Olga; Torrente-Fraga, Cristina; Gomez-Bertomeu, Frederic; Vila-Rovira, Angel; Hospital-Guardiola, Imma; de Diego-Cabanes, Cinta; Bejarano-Romero, Ferran; Rovira-Veciana, Dolors; Basora-Gallisa, Josep.
  • Vila-Corcoles A; Primary Health Care Service Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.
  • Satue-Gracia E; Unitat de Suport a la Recerca Tarragona-Reus, IDIAP Jordi Gol, Barcelona, Spain.
  • Ochoa-Gondar O; Primary Health Care Service Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.
  • Torrente-Fraga C; Unitat de Suport a la Recerca Tarragona-Reus, IDIAP Jordi Gol, Barcelona, Spain.
  • Gomez-Bertomeu F; Primary Health Care Service Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.
  • Vila-Rovira A; Unitat de Suport a la Recerca Tarragona-Reus, IDIAP Jordi Gol, Barcelona, Spain.
  • Hospital-Guardiola I; Department of Information and Communication Technologies, DAP Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.
  • de Diego-Cabanes C; Department of Microbiology, Hospital Universitari Joan XXIII, Institut Catala de la Salut, Tarragona, Spain.
  • Bejarano-Romero F; Unitat de Suport a la Recerca Tarragona-Reus, IDIAP Jordi Gol, Barcelona, Spain.
  • Rovira-Veciana D; Primary Health Care Service Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.
  • Basora-Gallisa J; Primary Health Care Service Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.
J Clin Hypertens (Greenwich) ; 22(8): 1379-1388, 2020 08.
Article in English | MEDLINE | ID: covidwho-671828
ABSTRACT
The use of some anti-hypertensive drugs in the current COVID-19 pandemic has become controversial. This study investigated possible relationships between anti-hypertensive medications use and COVID-19 infection risk in the ambulatory hypertensive population. This is a population-based retrospective cohort study involving 34 936 hypertensive adults >50 years in Tarragona (Southern Catalonia, Spain) who were retrospectively followed through pandemic period (from 01/03/2020 to 30/04/2020). Two data sets including demographic/clinical characteristics (comorbidities and cardiovascular medications use) and laboratory PCR codes for COVID-19 were linked to construct an anonymized research database. Cox regression was used to calculate multivariable hazard ratios (HRs) and estimate the risk of suffering COVID-19 infection. Across study period, 205 PCR-confirmed COVID-19 cases were observed, which means an overall incidence of 586.8 cases per 100 000 persons-period. In multivariable analyses, only age (HR 1.03; 95% CI 1.02-1.05; P < .001) and nursing home residence (HR 19.60; 95% CI 13.80-27.84; P < .001) appeared significantly associated with increased risk of COVID-19. Considering anti-hypertensive drugs, receiving diuretics (HR 1.22; 95% CI 0.90-1.67; P = .205), calcium channel blockers (HR 1.29; 95%CI 0.91-1.82; P = .148), beta-blockers (HR 0.97; 95% CI 0.68-1.37; P = .844), and angiotensin-converting enzyme inhibitors (HR 0.83; 95% CI 0.61-1.13; P = .238) did not significantly alter the risk of PCR-confirmed COVID-19, whereas receiving angiotensin II receptor blockers was associated with an almost statistically significant reduction risk (HR 0.67; 95% CI 0.44-1.01; P = .054). In conclusion, our data support that receiving renin-angiotensin-aldosterone system inhibitors does not predispose for suffering COVID-19 infection in ambulatory hypertensive people. Conversely, receiving angiotensin II receptor blockers could be related with a reduced risk.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / SARS-CoV-2 / COVID-19 / Hypertension / Antihypertensive Agents Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Clin Hypertens (Greenwich) Journal subject: Vascular Diseases Year: 2020 Document Type: Article Affiliation country: Jch.13948

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / SARS-CoV-2 / COVID-19 / Hypertension / Antihypertensive Agents Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Clin Hypertens (Greenwich) Journal subject: Vascular Diseases Year: 2020 Document Type: Article Affiliation country: Jch.13948